Delivery Order SPE2DB20D1100-SPE2DB25FD4B5
Award Date 7/14/25
Potential Completion Date 8/4/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Attruby 356 mg tablets (28-count packaging). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 16, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,556.44 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Attruby 356 mg tablets (28-count packaging). This is a firm fixed price, non-set-aside competitive delivery order with performance scheduled to conclude by September 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,778.22 to AmerisourceBergen Drug Corp for the supply of Attruby 356 mg tablets (28-count units). This firm fixed-price contract, issued on August 20, 2025, with completion targeted for September 11, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,778.22 to AmerisourceBergen Drug Corp for the supply of Attruby 356 mg tablets (28-count package). This firm fixed-price, competitively awarded delivery order was executed on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Attruby 356 mg tablets (28-count units) with a ceiling value of $12,778.22. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 6, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $12,778.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for ATTRUBY 356 mg tablets (28-count packages) on April 24, 2025, with an ultimate completion date of May 15, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a $12.78K delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count units) under a firm fixed-price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,334.66 to AmerisourceBergen Drug Corp for ATTRUBY 356 mg tablets (28 count) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The pharmaceutical supply will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $12.78K delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a $19,134.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count) with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of performance is...